摘要
研究目的旨在从膝骨性关节炎中医“证”的临床表现与现代医学一氧化氮和转化生长因子-β1的关系研究中,进一步探究膝骨性关节炎的病因病机;为继承和创新其临床规范标准,为提高本病辩证论治水平和疗效提供新的客观参考依据,进而为优化膝骨性关节炎手术及非手术治疗方案,减轻社会、家庭沉重经济、精神负担及提高患者生活质量贡献一份力量。
材料与方法研究对象为广东省中医院珠海医院骨科门诊及住院患者,按膝骨性关节炎的中医证侯诊断标准,纳入肾虚髓亏型(1组)及瘀血阻滞型(2组)膝骨性关节炎病人各40例做为观察组。另设有正常健康人(45岁以上)40例做对照组(3组)。按实验室检测指标规定要求分别予严格抽取静脉血,治疗前及治疗后对标本中一氧化氮(NO)和转化生长因子-β1(TGF-β1)指标进行检测,所得数据用SPSS13.0 forWindows软件进行统计分析,组间比较当P＜0.05时为差异有统计学意义。
结果治疗前,肾虚髓亏及瘀血阻滞两观察组中一氧化氮(NO)水平显著高于对照组(P＜0.01),且瘀血阻滞组高于肾虚髓亏组(P＜0.01);而转化生长因子-β1(TGF-β1)水平观显著低于对照组(P＜0.01),且瘀血阻滞组低于肾虚髓亏组(P＜0.01):NO和TGF-β1在1、2、3三组间分别做两两对比统计分析所得P值皆小于0.05(P＜0.05),其组间差异具有统计学意义。治疗后,观察组中NO水平均低于治疗前(P＜0.01),且瘀血阻滞组高于肾虚髓亏组(P＜0.01);TGF-β1水平均高于治疗前(P＜0.01),且瘀血阻滞组低于肾虚髓亏组(P＜0.01);NO和TGF-β1分别在1、2两组间对比分析所得P值皆小于0.05(P＜0.05),其组间差异具有统计学意义。
结论本实验研究结果说明一氧化氮(NO)和转化生长因子-β1(TGF-β1)在膝骨性关节炎疾病过程中发生了明显改变,NO和TGF-β1与膝骨性关节炎的发病有关。治疗后,NO和TGF-β1水平发生了变化,其治疗可能在一定程度上是通过NO和TGF-β1水平的变化而起效的。膝骨性关节炎的中医证型(瘀血阻滞、肾虚髓亏)与一氧化氮(NO)及转化生长因子-β1(TGF-β1)有一定的相关性。治疗前后NO和TGF-β1水平在膝骨性关节炎瘀血阻滞组和肾虚髓亏组之间的变化差异具有统计学意义。这对在膝骨性关节炎治疗中进一步进行中医药临床研究提供客观观察指标有积极的意义,有助于关于KOA中医辨证分型的客观研究并为此提供微观指标,同时在骨性关节炎的药物研究及临床治疗中观察NO和TGF-β1水平亦具有一定指导意义。
Objective:To study the Correlation between the clinical manifestation of TCM Syndromes of Knee Osteoarthritis and the level of Nitric oxide(NO)and Transforming growth factor -β1(TGF-β1)in modern medicine,further inquires into its cause of disease pathogenesis.In order to inherit and innovate the standard of clinical standard,to enhance the level of Syndrome Differentiation and Treatment of KOA and curative effect to provide the new objective reference,then to optimize the Knee Osteoarthritis surgery and the non-surgery therapeutic schedule,reduces the society,the family serious economy,the spiritual burden and improves the patient quality of life to contribute a strength..
Materials and method:study object for Guangdong Province Chinese medicine hospital Zhuhai Hospital orthopedics outpatient service and in hospital patient.The standard of diagnoses according to TCM Syndromes of Knee Osteoarthritis,From integrates with manifestation of the kidneys-marrow deficiency(1 group)separately and the blood stasis(2 groups)of Knee Osteoarthritis patient each 40 examples to do for the observation group.In addition is equipped with the normal healthy persons(above 45 years old)40 examples to make the control group(3 groups).Extracts the venous blood strictly according to the laboratory examination target establish requirements before and after treatment.Examine the target of Nitric oxide (NO)and Transforming growth factor -β1 in the specimen,And analyze the obtained data with SPSS13.0 for the Windows,the group compares,when(P＜0.05)The difference has statistics significance.
Results:Before treatment,the level of Nitric oxide(NO)of two Observer Group is significantly higher than the control group's(P＜0.01),and blood stasis group is higher than kidneys-marrow deficiency group(P＜0.01).But the level of transforming growth factor-β1(TGF-β1)was significantly lower than that of the control group(P＜0.01),and blood stasis group is lower than kidneys-marrow deficiency group(P＜0.01);Compared NO and TGF -β1 among the three groups,all P values of statistical analysis are less than 0.05 (P＜0.05),The inter-group difference between the groups was significant. After treatment,the level of NO of two Observer Group is significantly lower than that before treatment(P＜0.01),and blood stasis group was higher than that kidneys-marrow deficiency group(P＜0.01);The level of TGF-β1 is higher than that before treatment(P＜0.01),and blood stasis group is lower than kidneys-marrow deficiency group(P＜0.01);NO and TGF-β1 in 1,2 comparative analysis between the two groups,the P values are less than 0.05(P＜0.05), The difference between the groups was significant.
Conclusion:This study results show that nitric oxide(NO)and transforming growth factor -β1(TGF-β1)changed significantly in the disease process of Knee Osteoarthritis,The level of NO and TGF-β1 has relevance with knee osteoarthritis.After treatment,The level of NO and TGF-β1 has changed,its treatment may acts by the change of NO and TGF-β1 levels to a certain extent,The TCM Syndromes of Knee Osteoarthritis(blood stasis,kidneys-marrow deficiency)has certain relevance with Nitric oxide and Transforming growth factor -β1(TGF-β1).Before and after treatment, the changes of NO and TGF-β1 level in TCM Syndromes of Knee Osteoarthritis (blood stasis,kidneys-marrow deficiency)are statistical significant differences.This is positive for further clinical study of Chinese medicine in knee osteoarthritis treatment,and to provide an objective observation of the indicators as well,It is helpful'for TCM Syndromes of Knee Osteoarthritis and to provide micro-indicators,Meanwhile observing the level change of NO TGF-β1 in The drug research and clinical treatment of osteoarthritis is also a certain level of significance.
引文
[1]中国医学百科全书编辑委员会.免疫性疾病.风湿病学.上海科技出版社,1986,45-47.
[2]陈可冀.中西医结合实用临床急救.1999;6(1):3-4.
[3]王亦璁.骨与关节损伤.人民卫生出版社,1996.
[4]刘洪汪,刘志刚,孙宝金.中国骨伤,1997;10(4):27-28.
[5]李广德.中医杂志,2000;41(2):116-118.
[6]Hashizume H,Kawakami M,NishiH,etal.Spine,1997;22(10):1080-1084.
[7]毛宾尧,张学义,等.膝关节外科[M]1北京:人民卫生出版社出版,1999:351
[8]胥少汀,葛宝丰,等.实用骨科学(第二版)[M]1 北京:人民军医出版社,1992;1201.
[9]吴林生,金嫣莉.膝痛[M]1北京:人民卫生出版社,1997;347.
[10]J.P.Jackson,Waugh W.Surgery of the Knee Joint.Chapman and Hall Ltd,London,1984;279.
[11]施桂英编著1关节炎概要[M]1北京:中国医药科技出版社,2000;331.
[12]Soren A.Cooper N S,W augh TR.The nature and designation of osteoarth risis determined by its h istopathology[J].ClinExp Rheumato 1,1988;6(1):41-46.
[13]WeiXQ,wright Gc.SokoloffL.The effect of Sodium selenite on chondrocyes in monolager culture.Anthritis Rheum,1986;29:6602.
[14]翁习生.骨性关节炎病因研究进展[J].中华骨科杂志,1996,16(1):60.
[15]孙材江,王慧,杨锡兰,等.退行性膝关节氧自由基代谢的观察.中华骨科杂志,1992:12(6):4334.
[16]高春阳.一氧化氮在骨性关节炎发病机制中的作用[J].国外医学免疫学分册,2001;24(3):159.
[17]Pelletier JP.o steoarth ritis Cartilage,1999;7(3):308-3096.
[18]Grabow ski PS,Ralston SH,macpherson H.Br J Kneumato 1,1996;35:207-212.
[19]Pitsillides AA,Frenkeil S,Philip sM,etal.J FASEB,1995;9:1614.
[20]向孝兵,喻秀兵,严大波,等.前列腺素与骨性关节炎及调节.中医正骨,1999;11(12):53-54.
[21]Ben AV P,croffo rd LJ,Hla T,etal.Induction of vascularendo thelia grow th facto r exp ression in synovial fibro lblastsby p ro staglandin E and IL-1:a p ro tential inechanism for inflammato ry angiogenseis,FFBS Lett,1995:372:83.
[22]Am in RA.A tlurM,patel RN,et al.Superinduction of cycloxy- gense-2activity in human o steoarth ritis- affectedcartilage,influence of nitric oxide J Clin invest,1997:99(66):1231.
[23]Jvinen TA.Mo ilanen T.Jvinen TL.et al.Endoogenous nitric oxide and p ro staglandin E2 do no t regulate the synthesis of each o rther in interlenk iin-1 beta- stimulated rat articular cartilage.Inflammation,1996:20(6):683.
[24]潘海乐,王耶.IL-1与骨性关节炎研究新进展.中国老年医学杂志,2002;22(1):76-78.
[25]Sh inmeiM,M asda K,Kiknch i T,et al.Interlenk inl,tumo rnecro sis facto r.A nd interlenk in 6 asmediato rs of cartilage destruction.Sem in A rth ritis Rheam,1989:18(supp 1):27-32.
[26]Dean DD,Woessner JF.Extracts of human articularcartilage contain an inH ibito rof tiss metalcop ro teiaases.Biocem J,1984:218:231.
[27]潘海乐,姚跃,王国文,等.骨性关节炎模型动物血液关节液中IL-1水平检测.哈尔滨医科大学学报,2001;35(3)192-194.
[28]郑召民.骨性关节炎患者肿瘤坏死因子和白细胞介素6的测定及意义[J].中华矫形外科杂志,1998;5(6):544.
[29]邓廉夫,柴本甫.IL-1、TN F和IL-6与骨性关节炎.国外医学·创伤与外科基本问题分册,1996;17(2):102-106.
[30]Frenkel SR,Saadeh PB,Mehrara BJ,et al.Transforming growth factor beta superfamily members:role in cartilage modeling[J].Plast Reconstr Surg,2000:105(3):980-990.
[31]王玉彬,陈安民,郭风劲,等.骨关节炎患者软骨组织中TNF-α、TGF-β、IL-6、IL-9的表达变化及意义[J].山东医药,2007;47(12):11-12.
[32]马瑞雪.骨髓腔内压的测定及其临床意义[J].中华骨科杂志,1988:8(1):72.
[33]孙刚,王永锡.骨内静脉瘀滞、骨内高压在骨性关节炎发病中的作用初探[J].中华骨科杂志,1991:11(5):374.
[34]郭秦烯,田得祥,敖英芳,等.骨性关节炎关节软骨中(?)、(?)、(?)及调型胶原的分布.中国运动医学杂志,2002:21(3):228-231.
[35]Cooke TD,pathoyenic mechanism s in po lyarticular o steoarth ris.Clin Rheum D is,1985;11:203.
[36]Donohue JM,BussD,Oogema TA,et al.The effects of indirerct blunt trauma on adult canine articular cartilage.Jbone Jo int Surg(AM),1983;65:948.
[37]毕五蝉.膝关节载荷传导紊乱所致关节炎关节软骨退变[J].中华骨科杂志,1991:11(5):303.
[38]贺宪,魏春山,陈孝银.“肾主骨”在骨伤临床中运用[J]安徽中医学院学报,2004;23(1):4-6.
[39]Yuan GH,Masuko-Hongo K,katoT,etal.Immunologic intervention in the pathogenesis of osteoarthritis[J].Arthritis Rheum,2003;48(3):602-611
[40]贺宪,魏春山,蔡智刚,等.膝骨性关节炎的病机和防治机制探讨.山东中医杂志.2005:24(2):73-75.
[41]徐传毅,樊粤光,宁显明.肾虚血瘀与骨性关节炎关系初探[J]新中医,2002;34(3):8.
[42]吕爱平,李德新.脾肾虚弱导致衰老的机制探讨[J]辽宁中医杂志,2001;28(2):71_
[43]刘子君.骨关节病理学[M]1北京:人民卫生出版社,1990;389.
[44]张春礼,孙梁等.退行性膝骨关节炎病的关节镜下分型及治疗[J]1骨与关节损伤杂志,2001:16(4):284.
[45]张羽飞,王立德,等.膝关节骨性关节炎的关节镜下诊断与治疗[J]1中国内镜杂志,2000;6(5):46-47.
[46]Hashi zumeH,KawakamiM,NishiH,e t al.Spine,1997;22(10):1080-1084.
[47]邢宇彤.生理科学进展.1996;27(3)261-263.
[48]何炜,郭亭,转化生长因子-β与骨关节炎的软骨损伤修复[J].医学研究生学报,2007:20(2):195-198.
[49]Gerson C,Berhard.Report on innovative therapies in Rheumatic and autoimmune disease San Francisco[J].Rheuma21 st,2001:4:8-10.
[50]刘耀升.骨关节炎细胞凋亡与一氧化氮的调控作用[J].中国骨伤,2002;13(9):547.
[51]Gerson C,Berhard.Report on innovative therapies in Rheumatic and autoimmune disease San Francisco[J].Rheuma 21st,2001:4:8-10.
[52]黄枫.陈基长教授治疗膝骨性关节炎经验介绍[J].新中医,2005;37(6):68.